The jointly developed INTip Chemistry enables scientists to fully automate sample preparation at a fraction of the time, cost and effort of traditional SPE systems.
RENO, Nevada (July 28, 2016) — Hamilton Robotics and DPX Technologies, LLC (DPX®) have announced a collaboration leveraging their expertise in the fields of automated liquid handling and dispersive solid phase extraction to develop high-throughput solutions for clinical, forensic and food safety laboratories. The revolutionary INTip Chemistry merges the precision of Hamilton’s patented CO-RE® tip technology with DPX’s dispersive pipette extraction technology to generate the next phase in sample preparation. Laboratories may now automate their solid phase extraction (SPE) methodology with INTip Chemistry to significantly improve results at a fraction of the time, cost and effort of traditional SPE products.
Compatible on all Hamilton liquid handling workstations, Hamilton and DPX are using INTip Chemistry to drive increased value into the clinical, forensic and food safety markets, which are all under constant pressure to improve quality outcomes at a reduced cost. Hamilton’s versatile platforms offer throughput options for 4-, 8-, 96- and 384-samples, eliminating time-consuming manual pipetting steps which contribute to sample-to-sample variability.
Automated INTip Chemistry methods for clinical and forensic laboratories is the primary focus, with food safety applications to follow. Tip sizes range from 300 µL to 5 mL, supporting a variety of matrices including whole blood, serum, urine, oral fluid, tissue, meconium, fruits, and vegetables. Customization of the INTip Chemistry, by altering the tip size and the amount and type of resin, offers endless possibilities to personalize solutions specific to each laboratory’s unique analytical challenges and goals.
"While Hamilton has a demonstrated expertise in providing clinical and forensic laboratories with customized solutions, we have also focused on creating standardized solutions for a wide range of applications," said Michael Mouradian, Ph.D., Scientific Leader in Drug Discovery of Hamilton. "We are excited to work with DPX as this partnership broadens our SPE portfolio with industry validated methods for current
clinical, forensic and food safety matrices. By leveraging DPX's established network in the scientific community, we are able to deliver joint solutions to improve workflows and quality outcomes worldwide."
"Given the increased use of our dispersive pipette tips, we are responding to customers’ demands for enhanced throughput solutions,” said William Brewer, Ph.D., Founder, Chief Executive Officer of DPX. "By partnering with Hamilton to automate our SPE technology, DPX users can seamlessly scale up workflows with effective high-throughput automation.”